Leo Pharma Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 50222 (Leo Pharma Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
20
Package NDCs
10
Products
10
Active listings
0
Discontinued
5
Ingredients
2
Therapeutic classes
5
Dosage forms
4
With NADAC pricing
Portfolio
By therapeutic class
Top ingredients
By dosage form
Browse records — 10 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Adbry tralokinumab-ldrm 150 mg/mL INJECTION, SOLUTION | 50222-0346-02 | — | On market | View → |
| Adbry tralokinumab-ldrm 300 mg/2mL INJECTION, SOLUTION | 50222-0350-01 | — | On market | View → |
| Anzupgo delgocitinib 20 mg/g CREAM | 50222-0280-30 | — | On market | View → |
| Anzupgo delgocitinib 20 mg/g CREAM | 50222-0280-30 | — | On market | View → |
| ENSTILAR calcipotriene and betamethasone dipropionate 50 ug/g; .5 mg/g AEROSOL, FOAM | 50222-0302-60 | $21.837 /unit · NADAC | On market | View → |
| FINACEA FOAM azelaic acid .15 g/g AEROSOL, FOAM | 50222-0303-50 | $8.339 /unit · NADAC | On market | View → |
| SPEVIGO spesolimab 60 mg/mL INJECTION | 50222-0360-72 | — | On market | View → |
| SPEVIGO spesolimab 300 mg/2mL INJECTION | 50222-0362-01 | — | On market | View → |
| SPEVIGO spesolimab 150 mg/mL INJECTION | 50222-0361-02 | — | On market | View → |
| TACLONEX calcipotriene and betamethasone dipropionate 50 ug/g; .5 mg/g SUSPENSION | 50222-0501-06 | $20.697 /unit · NADAC | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.